Monitoring Agency Report issued by CRISIL Ratings Limited for the utilization of funds raised through Preferential Issue as approved by the Board and members of the Company in their respective meetings held on January 09, 2025 and February 05, 2025, for quarter ended September 30, 2025
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zota Health Care has submitted the Monitoring Agency Report issued by CRISIL Ratings Limited to the stock exchanges. The report tracks how the company has used the money raised through its Preferential Issue, which was first approved by the Board on January 9, 2025, and then by shareholders on February 5, 2025. This filing covers the quarter ending September 30, 2025. Such reports are required under SEBI rules whenever a listed company raises funds through preferential allotment to ensure the money is used for the stated purpose. The actual details of fund deployment and any observations by CRISIL would be in the full report attached to this filing.
This is a routine regulatory compliance filing and does not, by itself, signal any positive or negative event. Shareholders should review the attached CRISIL report to confirm that the raised funds are being deployed as originally disclosed, as any diversion of funds could be a concern.